CD274 and melanoma: Using mouse melanoma models, they also demonstrated that overexpression of Wnt/β-catenin is associated with T cell exclusion (resulting in “immune-desert” tumors) and resistance to anti-PD(L)-1 and anti CTLA-4 monoclonal antibody therapies[46].